First Vaccine Company Listed on the Hong Kong Stock Exchange as CanSinoBIO Debuts
Beijing and Hong Kong – Paul Hastings LLP, a leading global law firm, announced today that it has advised Morgan Stanley Asia Limited and CLSA Capital Markets Limited as joint sponsors in the US$160 million global offering and Hong Kong Stock Exchange IPO and listing of Chinese vaccine company CanSino Biologics Inc (“CanSinoBIO”).